Actively Recruiting
Study of Doliral Supplement Versus Placebo to Improve Quality of Life and Reduce Pelvic Pain in Women With Endometriosis
Led by Arafarma Group, S.A. · Updated on 2026-10-30
60
Participants Needed
1
Research Sites
6 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of the food supplement Doliral on quality of life and pelvic pain in women diagnosed with endometriosis. This study compares Doliral with a placebo over a period of several weeks to determine if it can improve symptoms and reduce pain intensity. The trial involves adult women with endometriosis stages I to III, focusing on those who experience moderate to severe pelvic pain. Participants will be randomly assigned to one of two groups one receiving Doliral and the other receiving a placebo. Both groups will take one buccal tablet daily from the baseline visit until the final visit. The study includes six visits in total, starting with a selection visit and continuing through baseline and follow-up visits up to 12 weeks. Participants will complete daily symptom diaries and use the visual analogue scale VAS to report pain intensity at each visit. Throughout the trial, participants will complete questionnaires about their quality of life and record their use of anti-inflammatory and pain medications. Researchers will monitor changes in pain intensity, quality of life improvements, and medication needs. The study includes safety monitoring and aims to measure episodes of clinically relevant symptoms. Participation lasts approximately 12 weeks from baseline to final visit, with assessments at regular intervals.
CONDITIONS
Brief Title
Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain.
Research Team
T
Tamara Rodríguez Araya, Dr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here